<VariationArchive VariationID="189241" VariationName="NM_001122764.3(PPOX):c.199del (p.Ala66_Leu67insTer)" VariationType="Deletion" Accession="VCV000189241" Version="8" RecordType="classified" NumberOfSubmissions="3" NumberOfSubmitters="3" DateLastUpdated="2024-02-20" DateCreated="2015-04-01" MostRecentSubmission="2024-02-20">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="187104" VariationID="189241">
      <GeneList>
        <Gene Symbol="PPOX" FullName="protoporphyrinogen oxidase" GeneID="5498" HGNC_ID="HGNC:9280" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>1q23.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="161165728" stop="161178013" display_start="161165728" display_stop="161178013" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="1" Accession="NC_000001.10" start="161136180" stop="161141009" display_start="161136180" display_stop="161141009" Strand="+" />
          </Location>
          <OMIM>600923</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_001122764.3(PPOX):c.199del (p.Ala66_Leu67insTer)</Name>
      <CanonicalSPDI>NC_000001.11:161167208:CCC:CC</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>1q23.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="161167209" stop="161167209" display_start="161167209" display_stop="161167209" variantLength="1" positionVCF="161167208" referenceAlleleVCF="GC" alternateAlleleVCF="G" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="1" Accession="NC_000001.10" start="161136999" stop="161136999" display_start="161136999" display_stop="161136999" variantLength="1" positionVCF="161136998" referenceAlleleVCF="GC" alternateAlleleVCF="G" />
      </Location>
      <OtherNameList>
        <Name>p.Leu67*</Name>
      </OtherNameList>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000001.10" sequenceAccession="NC_000001" sequenceVersion="10" change="g.161137001del" Assembly="GRCh37">
            <Expression>NC_000001.10:g.161137001del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000001.11" sequenceAccession="NC_000001" sequenceVersion="11" change="g.161167211del" Assembly="GRCh38">
            <Expression>NC_000001.11:g.161167211del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_012877.2" sequenceAccession="NG_012877" sequenceVersion="2" change="g.5821del">
            <Expression>NG_012877.2:g.5821del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000309.5" sequenceAccession="NM_000309" sequenceVersion="5" change="c.199del">
            <Expression>NM_000309.5:c.199del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000300.1" sequenceAccession="NP_000300" sequenceVersion="1" change="p.Ala66_Leu67insTer">
            <Expression>NP_000300.1:p.Ala66_Leu67insTer</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001587" Type="nonsense" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001122764.3" sequenceAccession="NM_001122764" sequenceVersion="3" change="c.199del" MANESelect="true">
            <Expression>NM_001122764.3:c.199del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001116236.1" sequenceAccession="NP_001116236" sequenceVersion="1" change="p.Ala66_Leu67insTer">
            <Expression>NP_001116236.1:p.Ala66_Leu67insTer</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001587" Type="nonsense" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001350128.2" sequenceAccession="NM_001350128" sequenceVersion="2" change="c.199del">
            <Expression>NM_001350128.2:c.199del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001337057.1" sequenceAccession="NP_001337057" sequenceVersion="1" change="p.Ala66_Leu67insTer">
            <Expression>NP_001337057.1:p.Ala66_Leu67insTer</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001587" Type="nonsense" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001350129.2" sequenceAccession="NM_001350129" sequenceVersion="2" change="c.-229del">
            <Expression>NM_001350129.2:c.-229del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001623" Type="5 prime UTR variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001350130.2" sequenceAccession="NM_001350130" sequenceVersion="2" change="c.-320del">
            <Expression>NM_001350130.2:c.-320del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001623" Type="5 prime UTR variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001350131.2" sequenceAccession="NM_001350131" sequenceVersion="2" change="c.-206del">
            <Expression>NM_001350131.2:c.-206del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001623" Type="5 prime UTR variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001365398.1" sequenceAccession="NM_001365398" sequenceVersion="1" change="c.199del">
            <Expression>NM_001365398.1:c.199del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001352327.1" sequenceAccession="NP_001352327" sequenceVersion="1" change="p.Ala66_Leu67insTer">
            <Expression>NP_001352327.1:p.Ala66_Leu67insTer</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001587" Type="nonsense" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001365399.1" sequenceAccession="NM_001365399" sequenceVersion="1" change="c.199del">
            <Expression>NM_001365399.1:c.199del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001352328.1" sequenceAccession="NP_001352328" sequenceVersion="1" change="p.Ala66_Leu67insTer">
            <Expression>NP_001352328.1:p.Ala66_Leu67insTer</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001587" Type="nonsense" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001365400.1" sequenceAccession="NM_001365400" sequenceVersion="1" change="c.-113del">
            <Expression>NM_001365400.1:c.-113del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001623" Type="5 prime UTR variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001365401.1" sequenceAccession="NM_001365401" sequenceVersion="1" change="c.-172del">
            <Expression>NM_001365401.1:c.-172del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001623" Type="5 prime UTR variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_1078" sequenceAccession="LRG_1078">
            <Expression>LRG_1078:g.5821del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_1078t1" sequenceAccession="LRG_1078t1">
            <Expression>LRG_1078t1:c.199del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_1078p1" sequenceAccession="LRG_1078p1" change="p.Ala66_Leu67insTer">
            <Expression>LRG_1078p1:p.Ala66_Leu67insTer</Expression>
          </ProteinExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA281488" DB="ClinGen" />
        <XRef Type="rs" ID="786204784" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_001122764.3(PPOX):c.199del (p.Ala66_Leu67insTer) AND Variegate porphyria" Accession="RCV000169672" Version="4">
        <ClassifiedConditionList TraitSetID="2387">
          <ClassifiedCondition DB="MedGen" ID="C0162532">Variegate porphyria</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2014-03-24" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_001122764.3(PPOX):c.199del (p.Ala66_Leu67insTer) AND not provided" Accession="RCV002515204" Version="3">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2022-07-16" SubmissionCount="2">Pathogenic/Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2022-07-16" NumberOfSubmissions="3" NumberOfSubmitters="3" DateCreated="2015-04-01" MostRecentSubmission="2024-02-20">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic/Likely pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">10486317</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">25714468</ID>
        </Citation>
        <DescriptionHistory Dated="2024-01-05">
          <Description>Pathogenic</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="2387" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="3370" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Variegate porphyria</ElementValue>
                <XRef ID="Variegate+porphyria/7355" DB="Genetic Alliance" />
                <XRef ID="MONDO:0008297" DB="MONDO" />
                <XRef ID="58275005" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Porphyria, South African type</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Protoporphyrinogen oxidase deficiency</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">PPOX deficiency</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">VP</ElementValue>
                <XRef Type="MIM" ID="176200" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="7848" />
                <XRef ID="7848" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Variegate porphyria (VP) is both a cutaneous porphyria (with chronic blistering skin lesions) and an acute porphyria (with severe episodic neurovisceral symptoms). The most common manifestation of VP is adult-onset cutaneous blistering lesions (subepidermal vesicles, bullae, and erosions that crust over and heal slowly) of sun-exposed skin, especially the hands and face. Other chronic skin findings include milia, scarring, thickening, and areas of decreased and increased skin pigmentation. Facial hyperpigmentation and hypertrichosis may occur. Cutaneous manifestations may improve in winter and be less prevalent in northern regions and in dark-skinned individuals. Acute neurovisceral symptoms can occur any time after puberty, but less often in the elderly. Acute manifestations are highly variable, but may be similar from episode to episode in a person with recurrent attacks; not all manifestations are present in a single episode; and acute symptoms may become chronic. Symptoms are more common in women than men. The most common manifestations are abdominal pain; constipation; pain in the back, chest, and extremities; anxiety; seizures; and a primarily motor neuropathy resulting in muscle weakness that may progress to quadriparesis and respiratory paralysis. Psychiatric disturbances and autonomic neuropathy can also be observed. Acute attacks may be severe and are potentially fatal.</Attribute>
                <XRef ID="NBK121283" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="practice guideline" Abbrev="Orphanet, 2007">
                <URL>https://www.orpha.net/data/patho/Pro/en/Emergency_AcuteHepaticPorphyria.pdf</URL>
                <CitationText>Orphanet, Acute hepatic porphyria neuro-visceral crisis, 2007</CitationText>
              </Citation>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">23409300</ID>
                <ID Source="BookShelf">NBK121283</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="Orphanet, 2007">
                <URL>https://www.orpha.net/data/patho/Pro/en/Emergency_CutaneousPorphyrias.pdf</URL>
                <CitationText>Orphanet emergency guideline: Cutaneous porphyrias, 2007</CitationText>
              </Citation>
              <XRef ID="79473" DB="Orphanet" />
              <XRef ID="C0162532" DB="MedGen" />
              <XRef ID="MONDO:0008297" DB="MONDO" />
              <XRef Type="MIM" ID="176200" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="399817" SubmissionDate="2015-03-06" DateLastUpdated="2015-04-01" DateCreated="2015-04-01">
        <ClinVarSubmissionID localKey="42704577|OMIM:176200" />
        <ClinVarAccession Accession="SCV000221207" DateUpdated="2015-04-01" DateCreated="2015-04-01" Type="SCV" Version="2" SubmitterName="Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine" OrgID="21766" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2014-03-24">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>The Leu67X variant in PPOX has not been previously reported in the literature nor identified in large population studies. This nonsense variant leads to a premature termination codon at position 67, which is predicted to lead to a truncated or absent protein. Heterozygous loss of function of the PPOX gene is an established disease mechanism in variegate porphyria. However, penetrance of this disease is variable, and many individuals with pathogenic variants in the PPOX gene do not have symptoms of the disease. In summary, this variant meets our criteria to be classified as pathogenic with reduced penetrance (http://pcpgm.partners.org/LMM).</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal dominant inheritance</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="AssertionMethod">LMM Criteria</Attribute>
          <Citation Type="general">
            <ID Source="PubMed">24033266</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>not provided</AffectedStatus>
              <FamilyData NumFamiliesWithVariant="1" />
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="1" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PPOX" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="1" alternateAllele="-" referenceAllele="C" start="161137001" stop="161137001" variantLength="1" />
            <GeneLocation>NM_000309.3:EXON 3</GeneLocation>
          </Location>
          <OtherNameList>
            <Name>NM_000309.3:c.199delC</Name>
            <Name>p.Leu67X</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000001.10:g.161137001delC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Porphyria variegata</ElementValue>
            </Name>
            <XRef DB="OMIM" ID="176200" Type="MIM" />
          </Trait>
        </TraitSet>
        <StudyName>CSER-MedSeq</StudyName>
        <SubmissionNameList>
          <SubmissionName>MedSeq_1</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7897997" SubmissionDate="2023-12-21" DateLastUpdated="2024-01-06" DateCreated="2024-01-06">
        <ClinVarSubmissionID localKey="1533697|Not provided" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004226533" DateUpdated="2024-01-06" DateCreated="2024-01-06" Type="SCV" Version="1" SubmitterName="Mayo Clinic Laboratories, Mayo Clinic" OrgID="500068" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-03-04">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">25714468</ID>
          </Citation>
          <Comment>PM2, PVS1</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="1" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PPOX" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <GeneLocation>NM_000309.5:exon 3</GeneLocation>
          </Location>
          <OtherNameList>
            <Name>p.Leu67*</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000309.5:c.199del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Not provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14104855</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="5911036" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-20" DateCreated="2023-02-07">
        <ClinVarSubmissionID localKey="17114188|MedGen:CN517202" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV003221742" DateUpdated="2024-02-20" DateCreated="2023-02-07" Type="SCV" Version="2" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-07-16">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">10486317</ID>
          </Citation>
          <Comment>For these reasons, this variant has been classified as Pathogenic. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. ClinVar contains an entry for this variant (Variation ID: 189241). This variant has not been reported in the literature in individuals affected with PPOX-related conditions. This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Leu67*) in the PPOX gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in PPOX are known to be pathogenic (PMID: 10486317).</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PPOX" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000001.10:g.161136999del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="CN517202" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12507860</SubmissionName>
          <SubmissionName>SUB14200279</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="5911036" TraitType="Disease" MappingType="XRef" MappingValue="CN517202" MappingRef="MedGen">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7897997" TraitType="Disease" MappingType="Name" MappingValue="Not provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="399817" TraitType="Disease" MappingType="Name" MappingValue="Porphyria variegata" MappingRef="Preferred">
        <MedGen CUI="C0162532" Name="Variegate porphyria" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

